Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).

Patient preference and adherence(2022)

引用 0|浏览5
暂无评分
摘要
Results of our trial are consistent with a slight improvement in viral suppression in a vulnerable population when a single tablet regimen is combined with patient-level adherence support. Beyond treatment simplicity and tolerability, tailored interventions addressing stigma and social determinants of health are still needed. The numerous challenges we encountered illustrate how randomised trials may not be the best approach for assessing adherence interventions in vulnerable populations.
更多
查看译文
关键词
HIV,adherence interventions,antiretroviral therapy,human immunodeficiency virus,single tablet regimen,vulnerable populations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络